ACTON, Mass. --(BUSINESS WIRE)--Aug. 26, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at three upcoming virtual investor conferences: The 2021 Virtual
ACTON, Mass. --(BUSINESS WIRE)--Aug. 16, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced FDA clearance for use of Eli Lilly and Company’s (NYSE: LLY) Lyumjev ® (insulin
ACTON, Mass. --(BUSINESS WIRE)--Aug. 11, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented the Omnipod DASH® Insulin Management System (Omnipod DASH) to healthcare providers
ACTON, Mass. --(BUSINESS WIRE)--Aug. 5, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended June 30, 2021 .
ACTON, Mass. --(BUSINESS WIRE)--Jul. 26, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at two upcoming virtual investor conferences: The Canaccord 41 st
ACTON, Mass. --(BUSINESS WIRE)--Jul. 1, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the second quarter of 2021 on August 5,
ACTON, Mass. --(BUSINESS WIRE)--Jun. 26, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced promising results from its latest pivotal trial for the Omnipod 5 Automated
ACTON, Mass. --(BUSINESS WIRE)--Jun. 24, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its schedule of events for the American Diabetes Association (ADA) Virtual 81 st
ACTON, Mass. --(BUSINESS WIRE)--May 6, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended March 31, 2021 .
ACTON, Mass. --(BUSINESS WIRE)--May 4, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at the virtual BofA Securities 2021 Health Care Conference on
ACTON, Mass. --(BUSINESS WIRE)--May 3, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the publication of its 2020 Sustainability Report.
ACTON, Mass. --(BUSINESS WIRE)--Apr. 29, 2021-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the pricing of a $500 million senior secured term loan B facility (the term
ACTON, Mass. --(BUSINESS WIRE)--Apr. 19, 2021-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that it has launched the syndication of new senior secured credit facilities,
ACTON, Mass. --(BUSINESS WIRE)--Apr. 5, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the first quarter of 2021 on May 6,
ACTON, Mass. --(BUSINESS WIRE)--Mar. 20, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced positive results from the first pivotal trial for the Omnipod ® 5 Automated
